search
Back to results

Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly (IRIDIA)

Primary Purpose

Myocardial Ischemia

Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
diagnosis reassessment
Diagnosis strategy and subsequent therapeutic reassessment
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Myocardial Ischemia focused on measuring Veterans

Eligibility Criteria

75 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: patients 75 of age or older hospitalized in a geriatric service and suspect of coronary heart disease Exclusion Criteria: acute myocardial infarction

Sites / Locations

  • Hopital Bichat

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

1

Arm Description

Diagnosis strategy and subsequent therapeutic reassessment All patients are in that arms. They all receive the diagnosis reassessment strategy.

Outcomes

Primary Outcome Measures

therapeutical impact of a reassessment strategy in the diagnosis of coronary heart disease in elderly

Secondary Outcome Measures

part link, in the treatment modification, with diagnosis reassessment and the part link with treatment optimization, death and rehospitalization in the subsequent 6 and 12 months

Full Information

First Posted
September 13, 2005
Last Updated
March 7, 2016
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT00224575
Brief Title
Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly
Acronym
IRIDIA
Official Title
Therapeutical Impact of a Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly
Study Type
Interventional

2. Study Status

Record Verification Date
March 2016
Overall Recruitment Status
Terminated
Why Stopped
End of recruitment period
Study Start Date
November 2004 (undefined)
Primary Completion Date
November 2005 (Actual)
Study Completion Date
November 2006 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Despite the effectiveness of beta-blockers and antiplatelet agents for secondary prevention of coronary heart disease, this treatments are underused in the elderly because of diagnosis uncertainty and underuse of efficient treatment. in a first time, diagnosis reassessment with invasive technique if necessary. in a second time, treatment reassessment.
Detailed Description
not desired

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myocardial Ischemia
Keywords
Veterans

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
260 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
Diagnosis strategy and subsequent therapeutic reassessment All patients are in that arms. They all receive the diagnosis reassessment strategy.
Intervention Type
Other
Intervention Name(s)
diagnosis reassessment
Other Intervention Name(s)
no other names to specified
Intervention Description
Strategy of diagnosis reassessment following a decision tree.
Intervention Type
Other
Intervention Name(s)
Diagnosis strategy and subsequent therapeutic reassessment
Intervention Description
Performed by geriatricians, following a decision tree, based on medical history, electrocardiogram, cardiac echotomography and stress scintigraphy
Primary Outcome Measure Information:
Title
therapeutical impact of a reassessment strategy in the diagnosis of coronary heart disease in elderly
Time Frame
during hospitalization
Secondary Outcome Measure Information:
Title
part link, in the treatment modification, with diagnosis reassessment and the part link with treatment optimization, death and rehospitalization in the subsequent 6 and 12 months
Time Frame
during hospitalization

10. Eligibility

Sex
All
Minimum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients 75 of age or older hospitalized in a geriatric service and suspect of coronary heart disease Exclusion Criteria: acute myocardial infarction
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
legrain sylvie
Organizational Affiliation
APHP
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hopital Bichat
City
Paris
ZIP/Postal Code
75018
Country
France

12. IPD Sharing Statement

Learn more about this trial

Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly

We'll reach out to this number within 24 hrs